Bio-Connect

InVivoMAb anti-mouse LFA-1alpha (CD11a)

BE0005-1
Bio X Cell
ApplicationsNeutralisation/Blocking
Product group Antibodies
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Bio X Cell
  • Product Name
    InVivoMAb anti-mouse LFA-1alpha (CD11a)
  • Delivery Days Customer
    7
  • Applications
    Neutralisation/Blocking
  • Certification
    Research Use Only
  • Clonality
    Monoclonal
  • Clone ID
    FD441.8
  • Concentration
    4-11 mg/ml
  • Estimated Purity
    >95%
  • Host
    Rat
  • Isotype
    IgG2b
  • Storage Instruction
    2°C to 8°C
  • UNSPSC
    12352203

References

  • Su CA, Iida S, Abe T, et al. Endogenous memory CD8 T cells directly mediate cardiac allograft rejection. Am J Transplant. 2014,14(3):568-79. doi: 10.1111/ajt.12605
    Read this paper
  • Setoguchi K, Hattori Y, Iida S, et al. Endogenous memory CD8 T cells are activated within cardiac allografts without mediating rejection. Am J Transplant. 2013,13(9):2293-307. doi: 10.1111/ajt.12372
    Read this paper
  • Ashkenazi E, Baranovski BM, Shahaf G, et al. Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy. PLoS One. 2013,8(5):e63625. doi: 10.1371/journal.pone.0063625
    Read this paper
  • Setoguchi K, Schenk AD, Ishii D, et al. LFA-1 antagonism inhibits early infiltration of endogenous memory CD8 T cells into cardiac allografts and donor-reactive T cell priming. Am J Transplant. 2011,11(5):923-35. doi: 10.1111/j.1600-6143.2011.03492.x
    Read this paper
  • Kish DD, Volokh N, Baldwin WM 3rd, et al. Hapten application to the skin induces an inflammatory program directing hapten-primed effector CD8 T cell interaction with hapten-presenting endothelial cells. J Immunol. 2011,186(4):2117-26. doi: 10.4049/jimmunol.1002337
    Read this paper
  • James SE, Orgun NN, Tedder TF, et al. Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice. Blood. 2009,114(27):5454-63. doi: 10.1182/blood-2009-08-232967
    Read this paper